Investors may want to put Idera Pharmaceuticals, Yamana Gold, and Ekso Bionics on their watchlists.
Key Data Points
Primary metrics and data points about EKSO BIONICS HOLDING.
of CAPS members think EKSO will outperform the market
What Fools think
62% Recommend to a Friend
0% Approve of CEOPowered by